Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Recommended
AI use in schools: How districts are making sure it's used as a study aid
Recommended
The sun now sets before 8 p.m. Will we ever do away with the time change?
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Sight Sciences, Inc.
Cigna Expands Coverage of Glaucoma Surgical Procedures to Include Canaloplasty and Goniotomy (Trabeculotomy)
June 21, 2023
From
Sight Sciences, Inc.
Via
GlobeNewswire
Tickers
SGHT
Sight Sciences Two Year Multicenter Study Results Show Sustained Reductions in Both Intraocular Pressure (IOP) and Glaucoma Medication Use in Mild-Moderate Primary Open Angle Glaucoma Patients Treated with a Procedure Enabled with the OMNI® Surgical
May 23, 2023
From
Sight Sciences, Inc.
Via
GlobeNewswire
Tickers
SGHT
Sight Sciences Announces 12-month Results from the First Minimally Invasive Glaucoma Surgery (MIGS) Comparative Analysis of Real-World Data (RWD) from the American Academy of Ophthalmology IRIS® Registry
May 06, 2023
From
Sight Sciences, Inc.
Via
GlobeNewswire
Tickers
SGHT
Sight Sciences Reports First Quarter 2023 Financial Results and Reaffirms Guidance for Full Year 2023
May 04, 2023
From
Sight Sciences, Inc.
Via
GlobeNewswire
Tickers
SGHT
Sight Sciences' Glaucoma and Dry Eye Technologies to be Featured in Multiple Clinical Presentations at the 2023 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting
May 01, 2023
From
Sight Sciences, Inc.
Via
GlobeNewswire
Tickers
SGHT
Sight Sciences to Present at the Upcoming Bank of America Securities 2023 Health Care Conference
April 26, 2023
From
Sight Sciences, Inc.
Via
GlobeNewswire
Tickers
SGHT
Sight Sciences to Report First Quarter 2023 Financial Results on May 4, 2023
April 20, 2023
From
Sight Sciences, Inc.
Via
GlobeNewswire
Tickers
SGHT
Sight Sciences to Host Surgical Glaucoma Investor Symposium on Friday, May 5, 2023
April 13, 2023
From
Sight Sciences, Inc.
Via
GlobeNewswire
Tickers
SGHT
Sight Sciences Appoints Ali Bauerlein as Chief Financial Officer
April 03, 2023
From
Sight Sciences, Inc.
Via
GlobeNewswire
Tickers
GLS
PEAR
SGHT
Sight Sciences Defeats Invalidity Challenges Filed By Alcon and Ivantis In The U.S. Patent Office
March 30, 2023
From
Sight Sciences, Inc.
Via
GlobeNewswire
Tickers
SGHT
Sight Sciences Reports Fourth Quarter and Full Year 2022 Financial Results
March 13, 2023
From
Sight Sciences, Inc.
Via
GlobeNewswire
Tickers
SGHT
Sight Sciences Launches the Ergo-Series of the OMNI® Surgical System
March 09, 2023
From
Sight Sciences, Inc.
Via
GlobeNewswire
Tickers
SGHT
Sight Sciences to Report Fourth Quarter and Full Year 2022 Financial Results on March 13, 2023
February 23, 2023
From
Sight Sciences, Inc.
Via
GlobeNewswire
Tickers
SGHT
Sight Sciences to Present at the Upcoming Citi 2023 Healthcare Services, Medtech, Tools & HCIT Conference
February 22, 2023
From
Sight Sciences, Inc.
Via
GlobeNewswire
Tickers
SGHT
Sight Sciences Announces 1,000th TearCare® Customer Installation
January 26, 2023
From
Sight Sciences, Inc.
Via
GlobeNewswire
Tickers
SGHT
Sight Sciences Announces Preliminary Unaudited Fourth Quarter and Full Year 2022 Financial Results
January 09, 2023
From
Sight Sciences, Inc.
Via
GlobeNewswire
Tickers
SGHT
Improvements in Signs and Symptoms of Dry Eye Disease From a Single TearCare® Treatment Sustained Through 12 Months
December 08, 2022
From
Sight Sciences, Inc.
Via
GlobeNewswire
Tickers
SGHT
Sight Sciences to Present at the Upcoming Piper Sandler 34th Annual Healthcare Conference
November 22, 2022
From
Sight Sciences, Inc.
Via
GlobeNewswire
Tickers
SGHT
Sight Sciences Reports Third Quarter 2022 Financial Results
November 10, 2022
From
Sight Sciences, Inc.
Via
GlobeNewswire
Tickers
SGHT
Sight Sciences Announces Publication of Clinical Data Demonstrating Standalone Effectiveness of the OMNI® Surgical System in Pseudophakic Glaucoma Patients with Uncontrolled Pressure Following a Previous Combination Cataract Stent Procedure
November 03, 2022
From
Sight Sciences, Inc.
Via
GlobeNewswire
Tickers
SGHT
Sight Sciences to Report Third Quarter 2022 Financial Results on November 10, 2022
October 20, 2022
From
Sight Sciences, Inc.
Via
GlobeNewswire
Tickers
SGHT
Sight Sciences Announces Publication of Data Showcasing Superior Symptoms Improvements with the TearCare® System Compared to LipiFlow* in Patients with Advanced Dry Eye Disease (DED)
September 29, 2022
From
Sight Sciences, Inc.
Via
GlobeNewswire
Tickers
SGHT
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.